Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response

被引:72
作者
Anumolu, SivaNaga S. [1 ]
Singh, Yashveer [1 ]
Gao, Dayuan [1 ]
Stein, Stanley [1 ]
Sinko, Patrick J. [1 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA
基金
美国国家卫生研究院;
关键词
Hydrogel; Ocular drug delivery; Pilocarpine; Poly(ethylene glycol); Pupil diameter; Sustained release; DRUG-DELIVERY SYSTEM; CONTROLLED-RELEASE; BIOAVAILABILITY; NANOPARTICLES; NITRATE; GELS;
D O I
10.1016/j.jconrel.2009.03.016
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Fast forming hydrogels prepared by crosslinking a poly(ethylene glycol) (PEG)-based copolymer containing multiple thiol (SH) groups were evaluated for the controlled ocular delivery of pilocarpine and subsequent pupillary constriction. Physical properties of the hydrogels were characterized using UV-Vis spectrophotometry, transmission electron microscopy (TEM), rheometry, and swelling kinetics. Pilocarpine loading efficiency and release properties were measured in simulated tear fluid. The hydrogel formulations exhibited high drug loading efficiency (similar to 74%). Pilocarpine release was found to be biphasic with release half times of similar to 2 and 94 h, respectively, and 85-100% of the drug was released over 8-days. Pilocarpine-loaded (2% w/v) hydrogels were evaluated in a rabbit model and compared to a similar dose of drug in aqueous solution. The hydrogels were retained in the eye for the entire period of the study with no observed irritation. Pilocarpine-loaded hydrogels sustained pupillary constriction for 24 h after administration as compared to 3 h for the solution, an 8-fold increase in the duration of action. A strong correlation between pilocarpine release and pupillary response was observed. In conclusion, the current studies demonstrate that in situ forming PEG hydrogels; possess the viscoelastic, retention, and sustained delivery properties required for an efficient ocular drug delivery system. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:152 / 159
页数:8
相关论文
共 49 条
[1]
Industrial perspective in ocular drug delivery [J].
Ali, Yusuf ;
Lehmussaari, Kari .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (11) :1258-1268
[2]
Banker G., 2002, MODERN PHARM
[3]
Rheological evaluation of Gelrite® in situ gels for ophthalmic use [J].
Carlfors, J ;
Edsman, K ;
Petersson, R ;
Jornving, K .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (02) :113-119
[4]
Chien YW., 1982, NOVEL DRUG DELIVERY
[5]
CORNEAL PERMEATION OF TOPICAL PILOCARPINE NITRATE IN RABBIT [J].
CHRAI, SS ;
ROBINSON, JR .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1974, 77 (05) :735-739
[6]
A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye [J].
Cohen, S ;
Lobel, E ;
Trevgoda, A ;
Peled, Y .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (2-3) :201-208
[7]
Properties and biocompatibility of chitosan films modified by blending with PVA and chemically crosslinked [J].
Costa, Ezequiel de Souza, Jr. ;
Pereira, Marivalda M. ;
Mansur, Herman S. .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2009, 20 (02) :553-561
[8]
Crank J., 1979, The mathematics of diffusion
[9]
In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine [J].
Desai, SD ;
Blanchard, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (02) :226-230
[10]
PEG drugs: an overview [J].
Greenwald, RB .
JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) :159-171